General Research
Model: rat
Inflation using hydrogen improves donor lung quality by regulating mitochondrial function during cold ischemia phase
Simplified Version Available
Breathe Easy: How Hydrogen Is Revolutionizing Lung Transplants
A recent study found that inflating donated lungs with hydrogen gas can improve their quality by regulating mitochondrial function. This breakthrough could lead to better outcomes for lung transplant patients. Hydrogen therapy is being explored for various health benefits, including lung disease treatment and chronic fatigue syndrome.
Read Simplified ArticleAbstract
Publish Year 2023 Country China Rank Positive Journal BMC Pulmonary Medicine Primary Topic Lung Secondary TopicSurgery/Transplantation Model Rat Tertiary TopicTransplantation/Graft Injury Vehicle Gas pH N/A Application Ventilation Comparison Complement
Background
Methods: Left donor lungs were inflated using 40% oxygen + 60% nitrogen (O group), or 3% hydrogen + 40% oxygen + 57% nitrogen (H group). Donor lungs were deflated in the control group and were harvested immediately after perfusion in the sham group (n = 10). Inflammation, oxidative stress, apoptosis, histological changes, mitochondrial energy metabolism, and mitochondrial structure and function were assessed. The expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were also analyzed.
Methods
Results: Compared with the sham group, inflammatory response, oxidative stress, histopathological changes, and mitochondrial damage were severe in the other three groups. However, these injury indexes were remarkably decreased in O and H groups, with increased Nrf2 and HO-1 levels, elevated mitochondrial biosynthesis, inhibition of anaerobic glycolysis and restored mitochondrial structure and function compared with the control group. Moreover, inflation using hydrogen contributed to stronger protection against mitochondrial dysfunction and higher levels of Nrf2 and HO-1 when comparing with O group. Conclusions: Lung inflation using hydrogen during CIP may improve donor lung quality by mitigating mitochondrial structural anomalies, enhancing mitochondrial function, and alleviating oxidative stress, inflammation, and apoptosis, which may be achieved through activation of the Nrf2/HO-1 pathway.